Intravenous Recombinant Human Prourokinase for Acute Medium Vessel Occlusion 4.5-24 Hours After Ischemic Stroke
Clinical trial NCT07776873 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07776873
- Sponsor
- The First Affiliated Hospital of Anhui Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-06
- Primary completion
- 2029-06-30
- Enrollment
- 616
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.